The role of SPECT scanning in a neuropsychiatry unit

Australian and New Zealand Journal of Psychiatry

Volumn 32, Issue 4, 1998, Pages 511-522

  Velakoulis, Dennis ^a   Lloyd, John H ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Frontotemporal dementia; Neuroimaging; Neuropsychiatry; SPECT

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; CLINICAL MEDICINE; DEMENTIA; EPIDEMIOLOGY; HEAD INJURY; HUMAN; IMAGING; LEWY BODY; MAJOR CLINICAL STUDY; MENTAL DISEASE; MULTIINFARCT DEMENTIA; NEUROLOGY; NEUROPSYCHIATRY; NEUROPSYCHOLOGICAL TEST; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0031873146     PISSN: 00048674     EISSN: None     Source Type: Journal    
DOI: 10.3109/00048679809068325     Document Type: Article

References (64)

1. Sachdev P. Neuropsychiatry. Australasian Psychiatry 1993; 1:108-110.
2. McKeith IG, Bartholomew PH, Irvine EM, Cook J, Adams R, Simpson AE. Single photon emission computerised tomography in elderly patients with Alzheimer's disease and multi-infarct dementia. Regional uptake of technetium-labelled HMPAO related to clinical measurements. British Journal of Psychiatry 1993; 163:597-603.
3. Curran SM, Murray CM, Van Beck M, Dougall N. A single photon emission computerised tomography study of regional brain function in elderly patients with major depression and with Alzheimer-type dementia. British Journal of Psychiatry 1993; 163:155-165.
4. O'Brien J, Eagger S, Syed G, Sahakian B, Levy R. A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry 1992 ; 55:1182-1187.
5. Dewan M, GUPTA S. Towards a definite diagnosis of Alzheimer's Disease. Comprehensive Psychiatry 1992: 33:282-290.
6. Borne F, Tintner R, Weiner M, Bigio E, White C. Brain blood flow in the dementias: SPECT with histopathological correlation. Radiology 1993; 186:361-365.
7. Pearlson G, Harris G, Powers R, Barta P, Camargo E, Chase G, Noga T, Tune L. Quantitative changes in mesial temporal volume, regional cerebral blood flow, and cognition in Alzheimer's Disease. Archives of General Psychiatry 1992; 49:402-408.
8. Hurwitz T, Ammann W, Chu D, Clark C, Holden J, Brownstone R. Single photon emission computed tomography using 99mTc-HMPAO in the routine evaluation of Alzheimer's Disease. Le Journal Canadien des Sciences Neurologiques 1991; 18:59-62.
9. Montaldi D, Brooks D, McColl J, Wyper D, Patterson J, Barren E, McCulloch J. Measurements of regional cerebral blood flow and cognitive performance in Alzheimer's disease. Journal of Neurology, Neuro surgery and Psychiatry 1990; 53:33-38.
10. The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia Journal of Neurology, Neurosurgery and Psychiatry 1994; 57:416-418.
11. Testa H, Snowden J, Neary D, Shields R, Burjan A, Prescott M, Northen B, Goulding P. The use of (99mTc)-HMPAO in the diagnosis of primary degenerative dementia Journal of Cerebral Blood Flow and Metabolism 1988; 8:S123-S126
12. Miller B, Cummings J, Villaneuva-Meyer J, Boone K, Mehringer C, Lesser 1, Mena 1 Frontal lobe degeneration: clinical, neuropsychological, and SPECT characteristics. Neurology 1991; 41:1374-1382.
13. Launes J, Sulkava R, Erkunjuntti T, Nikkinen P, Lindroth L, Liewendahl K, Liavanamen M. 99Tcm-HMPAO SPECT in suspected dementia. Nuclear Medicine Communications 1991; 12:757-765.
14. Neary D, Snowden JS, Shields RA et al. Single photon emission tomography using 99mTc-HMPAO in the investigation of dementia. Journal of Neurology, Neurosurgery and Psychiatry 1987; 50:1101-1109.
15. Jagust W, Reed B, Seab J, Kramer J, Budmger T. Clinical-physiologic correlates of Alzheimer's disease and frontal lobe dementia. American Journal of Physiologic Imaging 1989; 4:89-96.
16. Mesulam M, Weintraub S. Spectrum of primary progressive aphasia. In Rossor M, ed. Clinical neurology-unusual dementias. Sydney: Balliere Tindall. 1992:583-610.
17. Caselli R, Jack C, Petersen R, Wahner H, Yanagihara T. Asymmetric cortical degenerative syndromes: clinical and radiologie correlations. Neurology 1992; 42:1462-1468
18. Gemmell H, Sharp P, Smith F et al. Cerebral blood flow measured by SPECT as a diagnostic tool in the study of dementia. Psychiatry Research 1989; 29:327-329.
19. Wang S, Liu R, Lin K et al. Technetium-99m hexamethyl-propylene amine oxime single photon emission tomography of the brain in early Parkinson's disease: correlation with dementia and lateralization. European Journal of Nuclear Medicine 1993; 20:339-344.
20. Sawada H, Udaka F, Kameyama M et al. SPECT findings in Parkinson's disease associated with dementia. Journal of Neurology Neurosurgery and Psychiatry 1992; 55 963.
21. Liu R, Lin K, Wang S ET AL. Cognition and 99Tcm-HMPAO SPECT in Parkinson's disease. Nuclear Medicine Communications 1992; 13:744-748.
22. Kuiper M, Weinstein H, Bergmans P, Scheltens P, Wolters E (99mTc)-HMPAO SPECT and dementia in Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 1992; 55:981.
23. Spampinaio U, Habert M, Mas J et al. (99mTc)-HMPAO SPECT and cognitive impairment in Parkinson's disease: comparison with dementia of the Alzheimer type. Journal of Neurology, Neurosurgery and Psychiatry 1991; 54:787-792.
24. Pizzolato G. Dam M, Borsato N et al. 99mTc -HMPAO SPECT in Parkinson's disease. Journal of Cerebral Blood Flow and Metabolism 1988; 8:S101-S108.
25. Habert M, Spampinato U, Mas J et al. A comparative technetium 99m hexamethylpropyleneamine oxime SPECT study in different types of dementia. European Journal of Nuclear Medicine 1991; 18 3-11.
26. Holman B, Johnson K, Gerada B, Carvalho P, Satlin A. The scintigraphic appearance of Alzheimer's Disease: a prospective study using technetium-99m-HMPAO SPECT. Journal of Nuclear Medicine 1992; 33:181-185.
27. Fox P, Raichle M, Mintun M, Dence C. Non oxidative glucose consumption during focal physiologic neural activity. Science 1988; 241:462-464.
28. Lennox G. Lewy body dementia. In. Rossor M, ed Clinical neurology-unusual dementias, Sydney: Balliere Tindall, 1992:653-674.
29. Alexander G, DeLong M, Strick P. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual Review of Neuroscience 1986; 9:357-381.
30. Reid I, Besson J, Best P, Sharp P, Gemmell H, Smith F. Imaging of cerebral blood flow markers in Huntington's disease using single photon emission computed tomography. Journal of Neurology, Neurosurgery and Psychiatry 1988; 51 1264-1268.
31. Nagel J, Johnson K, Ichise M et al., Decreased iodine-123 IMP caudate nucleus uptake in patients with Huntington's disease. Clinical Nuclear Medicine 1988; 7:486-490.
32. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993; 72:1-20.
33. Devous M, Leroy R, Homan R. Single photon emission tomography in epilepsy. Seminars in Nuclear Medicine 1990; 20:325-341.
34. Shen W, Lee B, Park H et al. HIPDM-SPECT brain imaging in the presurgical evaluation of patients with intractable seizures. Journal of Nuclear Medicine 1990; 31:1280-1284.
35. Newton M, Greenwood R, Britton K et al. A study comparing SPECT with CT and MRI after closed head injury. Journal of Neurology. Neurosurgery and Psychiatry 1992; 55 92-94.
36. Weidmann K, Wilson J, Wyper D, Hadley D, Teasdale G, Brooks D. SPECT cerebral blood flow, MR imaging, and neuropsychological findings in traumatic head injury. Neuropsychology 1989; 3:267-281.
37. Goldenberg G, Podreka I, Pfaffelmayer N, Wessely P, Deecke L. Thalamic ischaemia in transient global amnesia: A SPECT study. Neurology 1991; 41:1748-1752.
38. Stillhard G, Landis T, Schiess R, Regard M, Sialer G. Bitemporal hypoperfusion in transient global amnesia: 99m-Tc-HMPAO SPECT and neuropsy chological findings during and after an attack. Journal of Neurology, Neurosurgery and Psychiatry 1990; 53:339-342.
39. Ichise M, Salit I, Abbey S, Chung D, Gray B, Kirsh J. Assessment of regional cerebral perfusion by 99Tcm-HMPAO SPECT in chronic fatigue syndrome. Nuclear Medicine Communications 1992; 13:767-772.
40. Henkes H, Huber G, Hierholzer J, Jaeger H, Hammann G. Piepgras U. Tempero-medial hot spot in HMPAO SPECT:Key findings in acute herpes simplex encephalitis. Radiology 1991; 181 (Suppl) : 173.
41. Masdeu J, Yudd A, Van Heertum R et al. Single photon emission computed tomography in human immunodeficiency virus encephalopathy: a preliminary report. Journal of Nuclear Medicine 1991; 32:1471-1475.
42. Velakoulis D, Pantelis C. What have we learned from functional imaging studies in schizophrenia? The role of frontal, striatal and temporal areas. Australian and New Zealand Journal of Psychiatry 1996; 30:192-209.
43. Rubin R. Villanueva-Meyer J, Ananth J, Trajmar P, Mena I. Regional xenon 133 cerebral blood flow and cerebral technetium 99m HMPAO uptake in unmedicated patients with obsessive-compulsive disorder and matched control subjects. Archives of General Psychiatry 1992; 49:695-702.
44. Machlin S, Harris G, Pearlson G, Hoehn-Saric R, Jeffery P, Camargo E. Elevated medial-frontal cerebral blood flow in obsessive-compulsive patients: a SPECT study. American Journal of Psychiatry 1991; 148:1240-1242.
45. Ebert D, Feistel H, Barocka A. Effects of sleep deprivation on the limbic system and the frontal lobes in affective disorders: a study with Tc-HMPAO. Psychiatry Research: Neuroimaging 1991; 40:247-251.
46. Mayberg H, Jeffery P, Wagner H, Simpson S. Regional cerebral blood flow in aptients with depression measured with Tc-99m HMPAO SPECT (abstract). Journal of Nuclear Medicine 1991:32:951.
47. Wechsler D. Wechsler adult intelligence scale-revised. New York: Psychological Corporation, 1981.
48. Wechsler D. Wechsler memory scale, New York: Psychological Corporation, 1973
49. Kaplan E, Goodglass H, Wemtraub S. Boston naming test. Philadelphia: Lea and Febiger, 1983.
50. Kendrick D, Gibson A, Mayes I. The revised Kendrick battery: clinical studies British Journal of Social and Clinical Psychology 1979; 18:329-340.
51. Christensen A. Luria's neuropsychological investigation. Los Angeles: Western Psychological Services, 1979.
52. Reitan R. Investigation of the validity of Halstead's measures of biological intelligence. Archives of Neurology and Psychiatry 1955; 48:475.
53. Burns A, Jacoby R, Levy R. Psychiatric phenomena in Alzheimer's disease, II. Disorders of perception. British Journal of Psychiatry 1990; 157:76-81.
54. Neary D, Snowden J, Northen B, Goulding P. Dementia of frontal lobe type. Journal of Neurology, Neurosurgery and Psychiatry 1988: 51:353-361.
55. Lishman W. Organic Psychiatry: the psychological consequences of cerebral disorder. Melbourne: Blackwell Science, 1987.
56. Alavi A, Hirsch L. Studies of central nervous system disorders with single photon emission computed tomography and positron emission tomography: evolution over the past 2 decades. Seminars in Nuclear Medicine 1991; XXI:58-81.
57. Kingsbury SJ, Salzman C. Disulfiram in the treatment of alcoholic patients with schizophrenia. Hospital and Community Psychiatry 1990: 41:133-134.
58. Soyka M. Psychopathological characteristics in alcohol hallucinosis and paranoid schizophrenia. Acta Psychiatrica Scandinavica 1990; 81:255-259.
59. Wilson-Barnett J, Trimble M. An investigation of hysteria using the IBQ. British Journal of Psychiatry 1985; 146:601-608.
60. Filley C, Davis K, Scmitz S et al. Neuropsychological performance and magnetic resonance imaging in Alzheimer's disease and normal aging. Neuropsychiatry, Neuropsychology and Behavioural Neurology 1989: 2:81-91.
61. Boffelli T, Guze S. The simulation of neurologic disease. Psychiatric Clinics of North America 1994: 15:301-310.
62. James L, Singer A, Zurynski Y et al Evoked response potentials and regional cerebral blood flow in somatization disorder. Psychotherapy and Psychosomatics 1987; 47:190-196.
63. Lazarus A. Cotterell K SPECT scan reveals abnormality in somatization disorder patient [letter]. Journal of Clinical Psychiatry 1989; 50:475-476.
64. Saxe G, Vasile R, Hill T, Bloomingdale K, van der Kolk B. SPECT imaging and multiple personality disorder [letter], Journal of Nervous and Mental Disease 1992; 180:662-663.